Annual FCF
$289.00M$70.74M+32.41%
Summary
- Current Value
- As of today, BIO annual free cash flow is $289.00M, up +32.41% on
- Historical Performance
- BIO annual free cash flow is up +152.62% over the past 3 years, and down -19.58% over the past 5 years
- All-Time High Comparison
- BIO annual free cash flow is currently -78.14% below its historical high of $1.32B set on
- 3-Year Low Comparison
- BIO annual free cash flow is +32.41% above its 3-year low of $218.26M reached on
- Sector Comparison
- BIO annual free cash flow is higher than 91.95% of companies in Healthcare sector
Free Cash Flow Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Free Cash Flow | $289.00M | +32.4% | +152.6% | -19.6% | +16.2% | |
| Quarterly Free Cash Flow | $89.20M | -27.7% | +106.5% | +137.6% | +94.0% | |
| TTM Free Cash Flow | $336.76M | +36.6% | +136.1% | +180.0% | +106.9% | |
| Price | $325.50 | -5.2% | -22.3% | -46.8% | +208.5% | |
| Annual Cash From Operations | $454.60M | +21.3% | +209.4% | -0.7% | +39.9% | |
| Annual CAPEX | $165.60M | +5.7% | +23.8% | +68.1% | +116.9% | |
| Annual Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Annual Net Income | -$1.84B | -189.4% | -143.3% | -204.9% | -1336.3% | |
| Annual Revenue | $2.57B | -3.9% | -12.2% | +11.0% | +43.8% |
Free Cash Flow Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.32B | N/A | -78.1% |
| 5Y | $1.32B | -78.1% | |
| All | $1.32B | -78.1% |
Free Cash Flow Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $218.26M | +32.4% | |
| 5Y | -$549.18M | +152.6% | |
| All | -$549.18M | +152.6% |
Free Cash Flow History
FAQ
What is the current annual free cash flow of BIO?
As of today, BIO annual free cash flow is $289.00M
What is 1-year change in BIO annual free cash flow?
BIO annual free cash flow is up +32.41% year-over-year
What is 3-year change in BIO annual free cash flow?
BIO annual free cash flow is up +152.62% over the past 3 years
How far is BIO annual free cash flow from its all-time high?
BIO annual free cash flow is currently -78.14% below its historical high of $1.32B set on December 31, 2022
How does BIO annual free cash flow rank versus sector peers?
BIO annual free cash flow is higher than 91.95% of companies in Healthcare sector
When is BIO next annual earnings release?
The next annual earnings release for BIO is on
Quarterly FCF
$89.20M$18.40M+25.99%
Summary
- Current Value
- As of today, BIO quarterly free cash flow is $89.20M, up +25.99% on
- Historical Performance
- BIO quarterly free cash flow is down -27.70% year-over-year, and up +106.47% over the past 3 years
- All-Time High Comparison
- BIO quarterly free cash flow is currently -93.06% below its historical high of $1.29B set on
- 3-Year Low Comparison
- BIO quarterly free cash flow is +126.39% above its 3-year low of -$337.99M reached on
- Sector Comparison
- BIO quarterly free cash flow is higher than 90.13% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Free Cash Flow | $89.20M | +26.0% | -27.7% | +106.5% | +137.6% | |
| Annual Free Cash Flow | $289.00M | – | +32.4% | +152.6% | -19.6% | |
| TTM Free Cash Flow | $336.76M | -9.2% | +36.6% | +136.1% | +180.0% | |
| Price | $325.50 | +5.3% | -5.2% | -22.3% | -46.8% | |
| Quarterly Cash From Operations | $120.90M | +3.8% | -26.1% | +109.0% | +155.7% | |
| Quarterly CAPEX | $31.70M | -30.6% | -21.2% | +15.0% | +58.7% | |
| Quarterly Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Net Income | -$341.90M | -207.6% | -152.3% | -110.0% | -126.0% | |
| Quarterly Revenue | $653.00M | +0.2% | +0.5% | -4.1% | +0.9% |
Quarterly Free Cash Flow Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $95.50M | -6.6% | |
| 3Y | $1.29B | N/A | -93.1% |
| 5Y | $1.29B | -93.1% | |
| All | $1.29B | -93.1% |
Quarterly Free Cash Flow Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $70.80M | +26.0% | |
| 3Y | -$337.99M | +126.4% | |
| 5Y | -$1.38B | +106.5% | |
| All | -$1.38B | +106.5% |
Quarterly Free Cash Flow History
FAQ
What is the current quarterly free cash flow of BIO?
As of today, BIO quarterly free cash flow is $89.20M
What is BIO quarterly free cash flow most recent change?
BIO quarterly free cash flow was up +25.99% on September 30, 2025
What is 1-year change in BIO quarterly free cash flow?
BIO quarterly free cash flow is down -27.70% year-over-year
How far is BIO quarterly free cash flow from its all-time high?
BIO quarterly free cash flow is currently -93.06% below its historical high of $1.29B set on December 31, 2022
How does BIO quarterly free cash flow rank versus sector peers?
BIO quarterly free cash flow is higher than 90.13% of companies in Healthcare sector
When is BIO next earnings release?
The next earnings release for BIO is on
TTM FCF
$336.76M$34.18M-9.21%
Summary
- Current Value
- As of today, BIO TTM free cash flow is $336.76M, down -9.21% on
- Historical Performance
- BIO TTM free cash flow is up +36.59% year-over-year, and up +136.08% over the past 3 years
- All-Time High Comparison
- BIO TTM free cash flow is currently -77.01% below its historical high of $1.46B set on
- 3-Year Low Comparison
- BIO TTM free cash flow is +256.76% above its 3-year low of -$214.82M reached on
- Sector Comparison
- BIO TTM free cash flow is higher than 91.59% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Free Cash Flow | $336.76M | -9.2% | +36.6% | +136.1% | +180.0% | |
| Annual Free Cash Flow | $289.00M | – | +32.4% | +152.6% | -19.6% | |
| Quarterly Free Cash Flow | $89.20M | +26.0% | -27.7% | +106.5% | +137.6% | |
| Price | $325.50 | +5.3% | -5.2% | -22.3% | -46.8% | |
| TTM Cash From Operations | $491.47M | -8.0% | +19.4% | +161.5% | +244.7% | |
| TTM CAPEX | $154.71M | -5.2% | -6.2% | +15.3% | +90.1% | |
| TTM Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| TTM Net Income | -$675.90M | -311.8% | +13.2% | +88.8% | -119.2% | |
| TTM Revenue | $2.56B | +0.1% | -0.9% | -8.8% | +7.5% |
TTM Free Cash Flow Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $370.94M | -9.2% | |
| 3Y | $1.46B | -77.0% | |
| 5Y | $1.46B | -77.0% | |
| All | $1.46B | -77.0% |
TTM Free Cash Flow Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $289.00M | N/A | +16.5% |
| 3Y | -$214.82M | +256.8% | |
| 5Y | -$933.41M | +136.1% | |
| All | -$933.41M | +136.1% |
TTM Free Cash Flow History
FAQ
What is the current TTM free cash flow of BIO?
As of today, BIO TTM free cash flow is $336.76M
What is BIO TTM free cash flow most recent change?
BIO TTM free cash flow was down -9.21% on September 30, 2025
What is 1-year change in BIO TTM free cash flow?
BIO TTM free cash flow is up +36.59% year-over-year
How far is BIO TTM free cash flow from its all-time high?
BIO TTM free cash flow is currently -77.01% below its historical high of $1.46B set on September 30, 2023
How does BIO TTM free cash flow rank versus sector peers?
BIO TTM free cash flow is higher than 91.59% of companies in Healthcare sector
When is BIO next earnings release?
The next earnings release for BIO is on
Free Cash Flow Formula
FCF = −
Data Sources & References
- BIO Official Website www.bio-rad.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/12208/000001220825000077/0000012208-25-000077-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/12208/000001220825000007/0000012208-25-000007-index.htm
- BIO Profile on Yahoo Finance finance.yahoo.com/quote/BIO
- BIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bio